Benefits versus risks of pharmacological prophylaxis to prevent symptomatic venous thromboembolism in unselected medical patients revisited. Meta-analysis of the medical literature

Journal of Thrombosis and Thrombolysis

Volumn 34, Issue 1, 2012, Pages 11-19

  Vardi, Moshe ^a,b   Steinberg, Michal ^b,c   Haran, Michal ^d   Cohen, Shai ^b,c  

^a HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

^b CARMEL MEDICAL CENTER   (Israel)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Internal medicine; Medical patients; Prophylaxis; Venous thromboembolism

Indexed keywords

DALTEPARIN; ENOXAPARIN; FONDAPARINUX; NADROPARIN; PLACEBO;

ASYMPTOMATIC DISEASE; BLEEDING; CHEMOPROPHYLAXIS; COHORT ANALYSIS; EMBASE; FOLLOW UP; HOSPITAL PATIENT; HUMAN; IMAGING; MEDICAL LITERATURE; MEDLINE; META ANALYSIS; META ANALYSIS (TOPIC); MORTALITY; NUMBERS NEEDED TO TREAT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM;

FEMALE; HUMANS; MALE; MEDLINE; META-ANALYSIS AS TOPIC; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84862754569     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-012-0730-x     Document Type: Review

References (39)

1. Antiplatelet Trialists' Collaboration (1994): Collaborative overview of randomised trials of antiplatelet therapy. III. Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. BMJ.;308:235-246
2. JA Heit MD Silverstein DN Mohr TM Petterson WM O'Fallon LJI Melton 2000 Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study Arch Intern Med 160 809 815 10737280 10.1001/archinte.160.6. 809 1:STN:280:DC%2BD3c7pvFGnsw%3D%3D
3. FAJ Anderson HB Wheeler RJ Goldberg 1991 A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study Arch Intern Med 151 933 938 2025141 10.1001/archinte.1991.00400050081016
4. SZ Goldhaber K Dunn RC MacDougall 2000 New onset of venous thromboembolism among hospitalized patients at Brigham and women's hospital is caused more often by prophylaxis failure than by withholding treatment Chest 118 1680 1684 11115458 10.1378/chest.118.6.1680 1:STN:280:DC%2BD3M%2FoslKltw%3D%3D
5. SZ Goldhaber VF Tapson 2004 A prospective registry of 5,451 patients with ultrasound-confirmed deep vein thrombosis Am J Cardiol 93 259 2562 14715365 10.1016/j.amjcard.2003.09.057
6. L Wein S Wein SJ Haas J Shaw H Krum 2007 Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients Arch Intern Med 14 1476 1486 10.1001/archinte.167.14.1476
7. AO Kanaan MA Silva JL Donovan T Roy AS Al-Homsi 2007 Meta-analysis of venous thromboembolism prophylaxis in medically ill patients Clin Ther 29 11 2395 2405 18158080 10.1016/j.clinthera.2007.11.015 1:CAS:528: DC%2BD1cXhtVKjurg%3D
8. F Dentali JD Douketis M Gianni W Lim MA Crowther 2007 Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients Ann Intern Med 146 278 288 17310052
9. WH Geerts D Bergqvist GF Pineo, et al. 2008 Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edn) Chest 133 Suppl 6 381S 453S 18574271 10.1378/chest.08-0656 1:CAS:528:DC%2BD1cXptVKhsrg%3D
10. R Duckit R Palsson L Bosanka L Dagna M Durusu Tanriover M Vardi, et al. 2010 Common diagnoses in internal medicine in Europe 2009: a pan-European, multi-centre survey Eur J Intern Med 21 5 449 452 10.1016/j.ejim.2010.06.012
11. AT Cohen VF Tapson JF Bergmann SZ Goldhaber AK Kakkar B Deslandes, et al. 2008 Venous thromboembolism risk and prophylaxis in the acute care setting (ENDORSE study): a multinational cross-sectional study Lancet 371 9610 387 394 18242412 10.1016/S0140-6736(08)60202-0
12. FA Anderson SZ Goldhaber VF Tapson JF Bergmann AK Kakkar B Deslandes, et al. 2010 Improving practices in US hospitals to prevent venous thromboembolism: lessons from ENDORSE Am J Med 123 12 1099 1106 21183004 10.1016/j.amjmed.2010. 07.011
13. N Kucher S Koo R Quiroz JM Cooper MD Paterno B Soukonnikov, et al. 2005 Electronic alerts to prevent venous thromboembolism among hospitalized patients N Engl J Med 352 969 977 15758007 10.1056/NEJMoa041533 1:CAS:528: DC%2BD2MXit1Wks7o%3D
14. FA Lederle JM Sacks L Fiore CS Landefeld N Steinberg RW Peters, et al. 2006 The prophylaxis of medical patients for thromboembolism pilot study Am J Med 119 1 54 59 16431185 10.1016/j.amjmed.2005.03.049
15. JP Metlay MJ Fine R Schulz TJ Marrie CM Coley WN Kapoor, et al. 1997 Measuring symptomatic and functional recovery in patients with community-acquired pneumonia J Gen Intern Med 12 7 423 430 9229281 10.1046/j.1525-1497.1997.00074.x 1:STN:280:DyaK2szntlansg%3D%3D
16. AR Jadad RA Moore D Carroll C Jenkinson DJ Reynolds DJ Gavaghan, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1 12 8721797 10.1016/0197-2456(95)00134-4 1:STN:280:DyaK28zgvVCmug%3D%3D
17. E von Elm DG Altman M Egger SJ Pocock PC Gøtzsche JP Vandenbroucke, et al. 2007 The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 1453 1457 10.1016/S0140-6736(07)61602-X
18. AT Cohen BL Davidson AS Gallus MR Lassen MH Prins W Tomkowski, et al. 2006 Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial BMJ 332 7537 325 329 16439370 10.1136/bmj.38733.466748.7C 1:CAS:528:DC%2BD28XitFSgsL0%3D
19. MM Samama AT Cohen JY Darmon L Desjardins A Eldor C Janbon, et al. 1999 A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients N Engl J Med 341 11 793 800 10477777 10.1056/NEJM199909093411103 1:CAS:528:DyaK1MXmtlGjsrs%3D
20. A Leizorovicz AT Cohen AGG Turpie CG Olsson PT Vaitkus SZ Goldhaber 2004 Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients Circulation 110 7 874 879 15289368 10.1161/01.CIR.0000138928.83266.24 1:CAS:528:DC%2BD2cXmtlOqtb4%3D
21. R Dahan D Houlbert C Caulin E Cuzin C Viltart M Woler, et al. 1986 Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-blind trial Haemostasis 16 2 159 164 3710294 1:STN:280:DyaL283itF2gsg%3D%3D
22. JF Bergmann E Neuhart 1996 A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group Thromb Haemost 76 4 529 534 8902991 1:CAS:528:DyaK28XmsFejsro%3D
23. G Gussoni M Campanini M Silingardi G Scannapieco A Mazzone G Magni, et al. 2009 In-hospital symptomatic venous thromboembolism and antithrombotic prophylaxis in internal medicine. Findings from a multicenter, prospective study Thromb Haemost 101 5 893 901 19404543 1:CAS:528:DC%2BD1MXmtV2hu70%3D
24. E Oger L Bressollette M Nonent K Lacut B Guias F Couturaud, et al. 2002 High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients Thromb Haemost 88 4 592 597 12362229 1:CAS:528:DC%2BD38XosVars7c%3D
25. FA Lederle D Zylla R MacDonald TJ Wilt 2011 Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American college of physicians clinical practice guideline Ann Intern Med 155 602 615 22041949
26. A Qaseem R Chou LL Humphrey M Starkey P Shekelle 2011 Physicians. ftCGCotACo. Venous thromboembolism prophylaxis in hospitalized patients: a clinical practice guideline from the American college of physicians Ann Intern Med 155 625 632 22041951
27. PT Vaitkus A Leizorovicz AT Cohen AG Turpie CG Olsson SZ Goldhaber, et al. 2005 Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients Thromb Haemost 93 76 79 15630494 1:CAS:528: DC%2BD2MXptVyntQ%3D%3D
28. C Engelke EJ Rummeny K Marten 2006 Pulmonary embolism at multi-detector row CT of chest: one year survival of treated and untreated patients Radiology 239 2 246 255 10.1148/radiol.2392050118
29. PL den Exter J Hooijer OM Dekkers MV Huisman 2011 Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients J Clin Oncol 29 17 2405 2409 10.1200/JCO.2010.34.0984
30. AT Cohen VF Tapson JF Bergmann SZ Goldhaber AK Kakkar B Deslandes, et al. 2008 Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study Lancet 371 9610 387 394 18242412 10.1016/S0140-6736(08)60202-0
31. S Barbar F Noventa V Rossetto A Ferrari B Brandolin M Perlati, et al. 2010 A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua prediction score J Thromb Haemost 8 2450 2457 20738765 10.1111/j.1538-7836.2010.04044.x 1:STN:280:DC%2BC3M7isVKrsA%3D%3D
32. National Institute for Health and Clinical Excellence-venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. Methods, evidence, and guidance: National Clinical Guideline Centre-acute and chronic conditions2010
33. R Alikhan AT Cohen S Combe MM Samama L Desjardins A Eldor, et al. 2003 Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study Blood Coagul Fibrinolysis 14 4 341 346 12945875 10.1097/00001721-200306000-00004 1:CAS:528:DC%2BD3sXltlejurg%3D
34. O Andrade Ede FA Binda AM Silva TD Costa MC Fernandes MC Fernandes 2009 Risk factors and prophylaxis for venous thromboembolism in hospitals in the city of Manaus, Brazil J Bras Pneumol 35 2 114 121 19287913 10.1590/S1806- 37132009000200003
35. S Weill-Engerer S Meaume A Lahlou F Piette O Saint-Jean A Sachet, et al. 2004 Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study J Am Geriatr Soc 52 8 1299 1304 15271117 10.1111/j.1532-5415.2004.52359.x
36. HR Buller AT Cohen B Davidson H Decousus AS Gallus M Gent, et al. 2007 Extended prophylaxis of venous thromboembolism with idraparinux N Engl J Med 357 11 1105 1112 17855671 10.1056/NEJMoa067703 1:CAS:528:DC%2BD2sXhtVKgtLzL
37. XY Li J Fan YQ Cheng Y Wang C Yao NS Zhong 2011 Incidence and prevention of venous thromboembolism in acutely ill hospitalized elderly Chinese Chin Med J 124 3 335 340 21362329
38. I Mahe JF Bergmann P D'Azemar JJ Vaissie C Caulin 2005 Lack of effect of a low-molecular-weight heparin (nadroparin) on mortality in bedridden medical in-patients: a prospective randomised double-blind study Eur J Clin Pharmacol 61 5-6 347 351 15981008 10.1007/s00228-005-0944-3 1:CAS:528:DC%2BD2MXmsFWlsL0%3D
39. JF Bergmann E Neuhart 1996 A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness Thromb Haemost 76 4 529 534 8902991 1:CAS:528:DyaK28XmsFejsro%3D